Curve Biosciences
Mountain View, California, United States · Biotechnology, Other · 26 employees
Curve Biosciences (“Curve”) is a company unlocking the potential of Chronic Epigenetics to bring precision to chronic disease care. Curve creates products that target the biological changes in tissues that result in the development and progression of chronic diseases. Curve’s Whole Body Tissue Atlas (WBTA) uniquely allows the company to discover these precise changes with data from over 250,000 ti
Funding history
- Funding Round — $40.0M — Oct 2025
- Funding Round — $17.7M — May 2024
Recent signals
- Apr 02, 2026: Curve Biosciences Appoints Dr. Amit Singal as Chief Medical Officer
- Oct 29, 2025: Raised $40.0M
- May 13, 2024: Raised $17.7M
See plans & pricing → Track Curve Biosciences’s funding, hiring, and signals — with verified contacts — on Fundz.